tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Novartis announces planned $23B investment over five years in U.S.
The FlyNovartis announces planned $23B investment over five years in U.S.
22h ago
NVS
Trump plans to announce ‘major’ tariff on pharmaceutical imports, Reuters says
PremiumThe Fly
Trump plans to announce ‘major’ tariff on pharmaceutical imports, Reuters says
2d ago
AZN
BMY
Travere Therapeutics price target lowered to $27 from $31 at BofA
PremiumThe Fly
Travere Therapeutics price target lowered to $27 from $31 at BofA
7d ago
NVS
TVTX
Novartis price target raised to CHF 115 from CHF 110 at Deutsche Bank
PremiumThe Fly
Novartis price target raised to CHF 115 from CHF 110 at Deutsche Bank
8d ago
NVS
Novartis gets FDA accelerated approval for Vanrafia
PremiumThe Fly
Novartis gets FDA accelerated approval for Vanrafia
9d ago
NVS
Needham healthcare analysts hold analyst/industry conference call
PremiumThe FlyNeedham healthcare analysts hold analyst/industry conference call
9d ago
JNJ
NVS
FDA approves Novartis radioligand therapy Pluvicto for earlier use in mCRPC
Premium
The Fly
FDA approves Novartis radioligand therapy Pluvicto for earlier use in mCRPC
14d ago
NVS
RFK Jr. plans to cut 10,000 jobs in HHS, WSJ reports
Premium
The Fly
RFK Jr. plans to cut 10,000 jobs in HHS, WSJ reports
15d ago
AZN
BMY
Large pharma M&A deals stalling amid volatile policies, Reuters reports
PremiumThe Fly
Large pharma M&A deals stalling amid volatile policies, Reuters reports
16d ago
AZN
BMY
Novartis put volume heavy and directionally bearish
PremiumThe Fly
Novartis put volume heavy and directionally bearish
17d ago
NVS
Morgan Stanley says Fabhalta’s label leaves opportunity for Apellis’ Empaveli
PremiumThe Fly
Morgan Stanley says Fabhalta’s label leaves opportunity for Apellis’ Empaveli
21d ago
NVS
APLS
Novartis gets third FDA approval for oral Fabhalta
PremiumThe Fly
Novartis gets third FDA approval for oral Fabhalta
22d ago
NVS
Novartis’s treatment of leishmaniasis granted FDA orphan designation
PremiumThe FlyNovartis’s treatment of leishmaniasis granted FDA orphan designation
22d ago
NVS
Novartis announces results from Phase III program for OAV101 IT
Premium
The Fly
Novartis announces results from Phase III program for OAV101 IT
23d ago
NVS
Trump Trade: Administration explores simplified plans for reciprocal tariffs
Premium
The Fly
Trump Trade: Administration explores simplified plans for reciprocal tariffs
24d ago
X
MS
Big pharma fears drug price spikes in US-EU tariff spat, Reuters says
PremiumThe Fly
Big pharma fears drug price spikes in US-EU tariff spat, Reuters says
24d ago
AZN
BMY
Novartis shareholders approve dividend increase to CHF 3.50 per share
PremiumThe Fly
Novartis shareholders approve dividend increase to CHF 3.50 per share
1M ago
NVS
Novartis announces CHMP of EMA adopted positive opinion for Fabhalta
PremiumThe Fly
Novartis announces CHMP of EMA adopted positive opinion for Fabhalta
1M ago
NVS
Novartis holder Emasan selling 26.5M shares, Bloomberg reports
PremiumThe Fly
Novartis holder Emasan selling 26.5M shares, Bloomberg reports
1M ago
NVS
Emasan files to sell 26.5M shares of Novartis, Bloomberg reports
PremiumThe FlyEmasan files to sell 26.5M shares of Novartis, Bloomberg reports
1M ago
NVS
Novartis’ Ianalumab granted FDA orphan designation
Premium
The Fly
Novartis’ Ianalumab granted FDA orphan designation
2M ago
NVS
Novartis downgraded to Neutral from Buy at UBS
Premium
The Fly
Novartis downgraded to Neutral from Buy at UBS
2M ago
NVS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >